Sanarus Medical will showcase its suite of breast care products, including its Visica System, which has predominately been used in the cryoablation of non-cancerous tumors called fibroadenomas. The Visica 2 Treatment System from Sanarus was recently selected as the exclusive technology to be utilized in the multicenter trial, “A Phase II Trial Exploring the Success of Cryoablation Therapy in the Treatment of Invasive Breast Carcinoma.”